Summit Therapeutics Competitors and Similar CompaniesClear all

Summit Therapeutics's competitors and similar companies include Teva, Torrent Pharmaceuticals and Divis Laboratories.

	Summit Therapeutics Summit Therapeutics is an international biopharmaceutical company focussed on the discovery and development of novel medicines to treat the fatal muscle wasting disease Duchenne muscular dystrophy and infections caused by the bacteria C. difficile.	Teva Teva is a pharmaceuticals company.	Torrent Pharmaceuticals Manufactures wide range of pharmaceutical products.	Divis Laboratories Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates.
Founding Date	Founding Date 2003	Founding Date 1901	Founding Date 1971	Founding Date 1990
Type	Type Public	Type Private	Type Public	Type Public
Tags	Tags Healthcare pharma	Tags Healthcare pharma	Tags Healthcare pharma	Tags Healthcare pharma
Locations	Locations Miami, US HQ Abingdon, GB Menlo Park, US	Locations HQ	Locations Ahmedabad, IN HQ São Paulo, BR Nürnberg, DE 32 No Market, IN Bengaluru, IN Chennai, IN Dahej, IN see more	Locations Hyderabad, IN HQ Choutuppal, IN Thondangi, IN Visakhapatnam, IN Basel, CH Basel, CH Florham Park, US
Employees	Employees 105	Employees 29,780	Employees 15,718	Employees 7,9267% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₹137.5b (FY, 2026)	Revenue (est.) ₹105.6b (FY, 2026)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods ₹35.3b (FY, 2026)	Cost of goods ₹40.9b (FY, 2026)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit ₹104.5b (FY, 2026)	Gross profit ₹69.7b (FY, 2026)
Net income	Net income ($1.1b) (FY, 2025)	Net income N/A	Net income ₹21.4b (FY, 2026)	Net income ₹25.7b (FY, 2026)